Active, not recruitingPhase 2NCT01797055
Apotransferrin in Atransferrinemia
Studying Congenital atransferrinemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Prothya Biosolutions
- Principal Investigator
- Cristina R Diaz de Heredia Rubio, PhD, MDVall d'Hebron, Spain
- Intervention
- Human apotransferrin(drug)
- Enrollment
- 5 enrolled
- Eligibility
- All sexes
- Timeline
- 2010 – 2028
Study locations (3)
- Klinikum Aschaffenburg, Aschaffenburg, Germany
- AO San Gerardo, Monza, Italy
- Vall d'Hebron Hospital, Barcelona, Spain
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01797055 on ClinicalTrials.gov